Hubbry Logo
HyperkeratosisHyperkeratosisMain
Open search
Hyperkeratosis
Community hub
Hyperkeratosis
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Hyperkeratosis
Hyperkeratosis
Hyperkeratosis
View on Wikipedia
from Wikipedia
Hyperkeratosis
Micrograph showing prominent hyperkeratosis in skin without atypia. H&E stain.
Pronunciation
SpecialtyDermatology Edit this on Wikidata

Hyperkeratosis is thickening of the stratum corneum (the outermost layer of the epidermis, or skin), often associated with the presence of an abnormal quantity of keratin,[1] and is usually accompanied by an increase in the granular layer. As the corneum layer normally varies greatly in thickness in different sites, some experience is needed to assess minor degrees of hyperkeratosis.

It can be caused by vitamin A deficiency or chronic exposure to arsenic.

Hyperkeratosis can also be caused by B-Raf inhibitor drugs such as vemurafenib and dabrafenib.[2]

It can be treated with urea-containing creams, which dissolve the intercellular matrix of the cells of the stratum corneum, promoting desquamation of scaly skin, eventually resulting in softening of hyperkeratotic areas.[3]

Types

[edit]

Follicular

[edit]

Follicular hyperkeratosis, also known as keratosis pilaris (KP), is a skin condition characterized by excessive development of keratin in hair follicles, resulting in rough, cone-shaped, elevated papules. The openings are often closed with a white plug of encrusted sebum. When called phrynoderma, the condition is associated with nutritional deficiency or malnourishment.

This condition has been shown in several small-scale studies to respond well to supplementation with vitamins and fats rich in essential fatty acids. Deficiencies of vitamin E,[4] vitamin A, and B-complex vitamins have been implicated in causing the condition.[5] Follicular hyperkeratosis is also a symptom in inherited collagen-related diseases of Ehlers-Danlos syndromes and Bethlem myopathy.

By other specific site

[edit]
  • Plantar hyperkeratosis is hyperkeratosis of the sole of the foot. It is recommended to surgically remove the dead skin, to provide symptomatic relief.
  • Hyperkeratosis of the nipple and areola is an uncommon benign, asymptomatic, acquired condition of unknown pathogenesis.[6]: 636 

Hereditary

[edit]

Other

[edit]
  • Hyperkeratosis lenticularis perstans (also known as "Flegel's disease"[7]) is a cutaneous condition characterized by rough, yellow-brown keratotic, flat-topped papules.[6]: 639 [7]

In mucous membranes

[edit]

The term hyperkeratosis is often used in connection with lesions of the mucous membranes, such as leukoplakia. Because of the differences between mucous membranes and the skin (e.g., keratinizing mucosa does not have a stratum lucidum and non keratinizing mucosa does not have this layer or normally a stratum corneum or a stratum granulosum), sometimes specialized texts give slightly different definitions of hyperkeratosis in the context of mucosae. Examples are "an excessive formation of keratin (e.g., as seen in leukoplakia)"[12] and "an increase in the thickness of the keratin layer of the epithelium, or the presence of such a layer in a site where none would normally be expected."[13]

Etymology and pronunciation

[edit]

The word hyperkeratosis (/ˌhaɪpərˌkɛrəˈtoʊsɪs/) is based on the Ancient Greek morphemes hyper- + kerato- + -osis, meaning 'the condition of too much keratin'.

Hyperkeratosis in dogs

[edit]

Nasodigitic hyperkeratosis in dogs may be idiopathic, secondary to an underlying disease, or due to congenital abnormalities in the normal anatomy of the nose and fingertips.

In the case of congenital anatomical abnormalities, contact between the affected area and rubbing surfaces is impaired. It is roughly the same with finger pads — in animals with an anatomical abnormality, part of the pad is not in contact with rubbing surfaces and excessive keratin deposition is formed. The idiopathic form of nasodigitic hyperkeratosis in dogs develops from unknown causes and is more common in older animals (senile form).[14][15] Of all dog breeds, Labradors, Golden Retrievers, Cocker Spaniels, Irish Terriers, Bordeaux Dogs are the most prone to hyperkeratosis.[16]

Therapy

[edit]

Since the deposition of excess keratin cannot be stopped, therapy is aimed at softening and removing it. For moderate to severe cases, the affected areas should be hydrated (moisturised) with warm water or compresses for 5-10 minutes. Softening preparations are then applied once a day until the excess keratin is removed.

In dogs with severe hyperkeratosis and a significant excess of keratin, it is removed with scissors or a blade. After proper instructions, pet owners are able to perform this procedure at home, and it may be the only method of correction.[17]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Hyperkeratosis

View on Grokipedia
from Grokipedia
Hyperkeratosis is a common characterized by the excessive thickening of the , the outermost layer of the , resulting from overproduction of , a tough protein that protects the skin. This thickening often manifests as rough, scaly patches or calluses and can occur anywhere on the body, though it is most frequently seen on areas subject to or , such as the hands, feet, elbows, and knees. The condition arises from a variety of causes, broadly categorized into those triggered by chronic physical or chemical stimuli and those linked to underlying medical or genetic factors. Chronic irritation from repeated friction, pressure, or exposure to harsh substances like aggressive soaps can lead to hyperkeratosis, commonly resulting in corns and calluses. Inflammatory disorders such as psoriasis or eczema, infections like warts caused by human papillomavirus, and autoimmune responses also contribute, while genetic mutations may cause inherited forms, including certain ichthyoses or palmoplantar keratodermas. Less commonly, it can stem from nutritional deficiencies (e.g., vitamin A), sun damage leading to actinic keratosis, drug side effects like chemotherapy, or allergies. Pathophysiologically, hyperkeratosis involves accelerated keratinocyte proliferation and impaired desquamation, where dead skin cells fail to shed normally, leading to accumulation. Symptoms typically include dry, rough, or hardened patches that may appear white, yellow, or discolored, often accompanied by itching, scaling, or fissuring. In pressure-related cases like corns, pain or tenderness upon contact is common, whereas non-pressure forms such as present as small, follicular bumps resembling . Certain variants, like , carry a of progression to if untreated, highlighting the importance of monitoring. Diagnosis generally involves a , review, and may include dermoscopy, , or patch testing to identify underlying causes. Treatment focuses on addressing the root cause and alleviating symptoms, often starting with conservative measures. Emollients and moisturizers help soften the skin, while keratolytics like or creams promote exfoliation by breaking down excess . For inflammatory or infectious types, topical corticosteroids, retinoids, or antifungal/antiviral agents may be prescribed, and procedures such as , therapy, or surgical are used for persistent lesions like corns or . varies by ; benign forms often resolve with management, but chronic or precancerous cases require ongoing care to prevent complications.

Overview

Definition

Hyperkeratosis is a dermatopathological condition characterized by the thickening of the , the outermost layer of the , due to excessive production or retention of , a tough fibrous protein that forms the skin's protective barrier. This thickening occurs when , the primary cells of the , undergo accelerated proliferation or fail to desquamate normally, leading to an accumulation of anucleate corneocytes filled with filaments. In normal skin, plays a crucial role in maintaining the barrier function of the by providing mechanical strength and preventing water loss and entry. Hyperkeratosis specifically affects this layer without altering the underlying epidermal maturation process in its orthokeratotic form, where nuclei are absent in the thickened . It is important to distinguish hyperkeratosis from related conditions: parakeratosis involves the retention of nuclei in the , indicating incomplete keratinization often seen in inflammatory disorders, while acanthosis denotes hyperplasia and thickening of the prickle cell (spinous) layer beneath the . The term hyperkeratosis entered dermatological literature in the , with its earliest recorded use in by British surgeon William Lawrence, describing skin changes associated with chronic irritation.

Epidemiology

Hyperkeratosis encompasses a range of conditions characterized by excessive accumulation, with prevalence varying significantly by type and population subgroup. , a common precancerous form linked to exposure, has a global prevalence of approximately 14% in the general adult population, based on a of observational studies. Other forms, such as frictional hyperkeratosis manifesting as corns and calluses, affect up to 78% of individuals in community-dwelling older adults, though many cases are and underdiagnosed. , a follicular variant, impacts about 40% of adults worldwide. Demographic trends reveal higher occurrence in older adults due to cumulative environmental exposures, with actinic keratosis prevalence reaching 40-60% among those over 40 in high-UV regions like . It is more prevalent in fair-skinned individuals, particularly Caucasians, where rates of actinic keratosis can exceed 10-20% in those over 40 years old, compared to much lower incidences in darker-skinned populations. Gender differences are notable in frictional types; corns and calluses show a 4:1 female-to-male , often attributed to footwear like high heels that increase pressure on the feet. In contrast, actinic keratosis is more common in men, with prevalence rates of 49% versus 28% in women, linked to occupational sun exposure. Geographic variations are pronounced, with higher rates of sun-induced hyperkeratosis in sunny, temperate, and subtropical areas; prevalence ranges from 11-26% in temperate zones and increases toward equatorial regions due to elevated UV radiation. For instance, rates are substantially higher in compared to or the , reflecting differences in UV intensity and skin phototypes. In tropical areas, while UV exposure is intense, hyperkeratosis may be underreported due to limited diagnostic access and focus on infectious dermatoses. As of 2025, incidence trends indicate an increase linked to aging populations and , which amplifies UV exposure through and shifting weather patterns, potentially elevating rates in previously low-risk areas. Projections for keratinocyte-related conditions, including hyperkeratosis precursors, suggest rising burdens by 2050, driven by demographic shifts.

Pathophysiology

Normal Skin Keratinization

The process of normal skin keratinization begins in the , the deepest layer of the , where proliferate through to replenish the epidermal sheet. These basal differentiate as they migrate upward through the and , undergoing biochemical changes that culminate in the formation of the . In this outermost layer, transform into anucleated corneocytes filled with filaments embedded in a lipid matrix, providing a protective barrier. The entire lifecycle from basal proliferation to desquamation of corneocytes from the skin surface typically takes 40-56 days in healthy adults, ensuring continuous renewal of the epidermal barrier. Central to this process are keratins, the primary structural proteins in keratinocytes, which assemble into intermediate filaments to provide mechanical strength. Keratins are divided into type I (acidic, low molecular weight) and type II (basic or neutral, higher molecular weight) families; in epidermal keratinocytes, pairs such as K1/K10 or K5/K14 form obligate heterodimers that polymerize into 10-nm filaments, crosslinking with other cytoskeletal elements during differentiation. is maintained by desmosomes, calcium-dependent junctions composed of cadherins (desmogleins and desmocollins) linked to keratin filaments via plaque proteins like desmoplakin, ensuring structural integrity as cells migrate. In the , desmosomes modify into corneodesmosomes, reinforced by corneodesmosin, which sustains cohesion among corneocytes until controlled degradation allows . Keratinization is tightly regulated by extracellular and intracellular signals to coordinate proliferation, differentiation, and shedding. A key regulator is the calcium gradient across the , which increases from low levels in the basal layer (~0.1 mM) to high concentrations in the granular layer (~1.0-1.5 mM), activating calcium-sensing receptors that trigger keratinocyte differentiation, desmosome assembly, and expression of cornification proteins. Proteases, particularly kallikrein-related peptidases (KLKs) such as KLK5, KLK7, and KLK8 secreted in the , degrade corneodesmosomes and intercellular lipids under pH control (acidic in the ), facilitating orderly without . In the granular layer, undergo , an apoptosis-like process involving caspase-14 activation, organelle degradation, and nuclear , converting viable cells into dead corneocytes while preventing barrier disruption.

Mechanisms of Hyperkeratosis

Hyperkeratosis arises from disruptions in the normal process of keratinization, where excessive accumulation of in the occurs due to either impaired shedding or accelerated production of . Two primary mechanisms contribute to this pathology: retention hyperkeratosis and proliferative hyperkeratosis. Retention hyperkeratosis involves incomplete resulting from defective degradation of corneodesmosomes, the intercellular junctions that maintain cohesion in the . These structures, composed of proteins such as corneodesmosin, desmoglein 1, and desmocollin 1, are normally broken down by proteases like kallikreins 5 and 7 (KLK5 and KLK7), whose activity is regulated by factors including skin pH and hydration. Impaired degradation, often due to inhibition of these proteases (e.g., by elevated in conditions like ), leads to persistent corneodesmosomes and buildup of corneocytes, thickening the . Proliferative hyperkeratosis, in contrast, stems from heightened keratinocyte proliferation in the basal layers of the , driven by cytokines and s. Cytokines such as interleukin-1 (IL-1) and IL-6 stimulate the release of keratinocyte growth factor (KGF) through , promoting mitotic activity and epidermal . Similarly, transforming growth factor-alpha (TGF-α) binds to the (EGFR) on basal keratinocytes, activating pathways like MAPK to enhance and contribute to stratum corneum thickening. This mechanism is particularly prominent in inflammatory skin disorders, where sustained signaling amplifies keratinocyte turnover beyond normal rates. Hyperkeratotic changes manifest histologically as orthokeratotic or parakeratotic forms, reflecting differences in maturation. Orthokeratotic hyperkeratosis features a thickened composed of anucleate corneocytes with preserved maturation, often exhibiting a compact or laminated appearance without nuclear retention. Parakeratotic hyperkeratosis, however, shows retained nuclei in the due to accelerated transit and incomplete differentiation, commonly associated with inflammatory states that disrupt the normal keratinization sequence. These forms highlight how disruptions in or proliferation alter the final architecture of the layer. At the molecular level, key players in hyperkeratosis include upregulated genes encoding cornified envelope proteins such as involucrin and loricrin, which are crosslinked by transglutaminases to form a robust barrier. In response to barrier disruption, involucrin expression extends across the spinous layer with an extracellular staining pattern, while loricrin shows alternating upregulation in the granular layer, enhancing cornified envelope formation and contributing to thickening. mutations, particularly loss-of-function variants in the FLG gene, exacerbate this by impairing barrier integrity; reduced processing leads to decreased natural moisturizing factors, altered pH, and diminished water-holding capacity, triggering compensatory epidermal and hyperkeratosis as seen in .

Causes and Risk Factors

Acquired Causes

Acquired hyperkeratosis arises from external environmental, lifestyle, or disease-related factors that disrupt normal keratinization without involving inherited genetic mutations. These triggers lead to excessive production and retention of in the , often as a protective response to chronic or inflammation. Common examples include mechanical trauma, ultraviolet radiation, inflammatory dermatoses, infections, chemical exposures, and iatrogenic effects from medications. Mechanical factors, such as repeated and , are primary causes of localized hyperkeratosis, resulting in calluses and corns. Calluses form as diffuse thickening of the skin in areas like the palms or soles due to ongoing shear forces, while corns develop pointed, conical hyperkeratotic plugs from concentrated , often on the feet from ill-fitting shoes or high-heeled . These lesions represent a reactive of the to protect underlying tissues, with histological features including compact orthokeratosis and mild acanthosis. Chronic (UV) exposure from or tanning beds induces , a precancerous form of hyperkeratosis characterized by rough, scaly patches on sun-exposed areas like the face, , and hands. This occurs due to cumulative DNA damage in from UVB rays, leading to disordered keratinocyte proliferation and atypical hyperkeratosis. Risk escalates with prolonged outdoor occupations, such as farming or , where cumulative exposure exceeding five years significantly heightens incidence, particularly in fair-skinned individuals. Inflammatory conditions like and eczema promote reactive hyperkeratosis through immune-mediated epidermal . In , T-cell driven causes rapid turnover, resulting in thick, silvery scales from parakeratotic hyperkeratosis overlying erythematous plaques. Eczema, particularly chronic atopic or hyperkeratotic hand variants, leads to lichenified hyperkeratosis from persistent scratching and barrier disruption, with thickened palms and fissuring due to ongoing release. These processes amplify epidermal proliferation in response to inflammatory signals. Infections and irritants also trigger hyperkeratosis as a secondary response. Human papillomavirus (HPV) infection causes (verrucae) with marked papillomatous hyperkeratosis and formation, often on hands or feet from direct contact or microtrauma. Chemical irritants, such as chronic exposure from contaminated water or industrial sources, produce diffuse palmoplantar hyperkeratosis with punctate keratoses and pigmentation, typically after years of accumulation leading to toxic epidermal changes. Iatrogenic causes include certain medications that induce transient or persistent hyperkeratosis as adverse effects. agents, particularly those causing hand-foot skin reaction like or taxanes, result in painful hyperkeratotic plaques on palms and soles due to direct toxicity and inflammation. inhibitors, such as or , similarly provoke through disrupted epidermal signaling pathways. These effects are often reversible upon discontinuation but can be exacerbated by underlying genetic predispositions that heighten skin reactivity.

Genetic Causes

Genetic causes of hyperkeratosis primarily involve inherited in genes critical for epidermal differentiation and keratinization, leading to disorders characterized by excessive accumulation in the skin. These conditions are typically autosomal dominant or recessive and manifest from birth or with varying degrees of palmoplantar, nail, or generalized hyperkeratosis. Pachyonychia congenita (PC) is an autosomal dominant caused by heterozygous mutations in one of five keratin genes: KRT6A, KRT6B, KRT6C, KRT16, or KRT17, which encode proteins expressed in epithelial tissues such as the nail bed and palmoplantar . These mutations disrupt filament assembly, resulting in cytoskeletal fragility and compensatory hyperkeratosis, particularly focal and painful nail . Mutations in KRT6A and KRT16 are most common, accounting for approximately 70-80% of cases, while KRT17 mutations often involve oral alongside skin findings. Vörner syndrome, also known as epidermolytic (EPPK), arises from autosomal dominant mutations in the , which encodes a type I specifically expressed in suprabasal palmoplantar . These mutations, often in the rod domain (e.g., p.Arg162Trp hotspot), cause with diffuse, yellow-brown thickening of the palms and soles, sometimes extending to knuckles or Achilles tendons, due to impaired network stability and epidermal blistering. Unlike other keratodermas, EPPK spares nails and lacks widespread involvement. In other ichthyoses, such as , autosomal recessive mutations in the TGM1 gene lead to 1 deficiency, impairing cornified envelope formation and resulting in generalized fine-scale hyperkeratosis covering the body, often with and collodion membrane at birth. TGM1 encodes an enzyme essential for cross-linking proteins in the , and biallelic loss-of-function variants cause defective barrier function and hyperproliferative scaling. These genetic hyperkeratosis disorders are rare, with prevalence estimates ranging from 1 in 100,000 to 500,000 individuals worldwide, though exact figures vary by subtype; for instance, PC has an estimated prevalence of about 1 in 500,000, while has an incidence of about 1 in 200,000-300,000 live births. Most follow autosomal dominant inheritance (e.g., PC, Vörner syndrome), with 50% risk to offspring, whereas is autosomal recessive, requiring carrier parents. As of 2025, approaches targeting mutations show promise in early-stage studies. For TGM1-deficient , topical delivery of KB105 (an AAV2 vector expressing functional TGM1) has demonstrated safety and preliminary efficacy in phase 1/2 s, reducing scaling and improving in affected skin. Preclinical / editing of KRT9 mutations in models of EPPK has reduced mutant protein expression by up to 15%, alleviating hyperkeratosis, with human s anticipated. Similar allele-specific silencing strategies for PC mutations, such as the Phase 1b of TD101 siRNA which showed some clinical improvement in calluses, continue in as of 2025.

Types

Common Cutaneous Types

Corns and calluses are among the most common forms of hyperkeratosis, resulting from chronic friction or pressure on the skin, leading to localized thickening. Corns typically form on toes or feet as conical, painful lesions with a hard core, while calluses are broader, painless areas often on hands or soles. These acquired conditions affect a significant portion of , particularly those in occupations involving manual labor or ill-fitting footwear, and are benign but can cause discomfort if unmanaged. Actinic keratosis represents one of the most prevalent forms of cutaneous hyperkeratosis, manifesting as rough, scaly patches on sun-exposed due to chronic (UV) radiation damage. These premalignant lesions arise from atypical proliferation in the and are considered early indicators of risk. The condition primarily affects fair-skinned individuals with prolonged sun exposure, with prevalence estimates ranging from 11% to 60% among Caucasians over 40 years of age. Seborrheic keratosis is a benign epidermal proliferation characterized by waxy, stuck-on-appearing growths that often develop in multiples on the trunk, face, or extremities of older adults. These lesions result from clonal expansion of and are histologically marked by hyperkeratosis, acanthosis, and horn cysts, though their exact remains unclear, with associations to aging and possibly UV exposure. increases markedly with age, affecting over 80% of individuals older than 50 years and nearing 100% in those over 60. Keratosis pilaris is a frequent follicular hyperkeratosis presenting as small, rough, follicular papules or plugs, commonly on the upper arms, thighs, and cheeks, due to abnormal keratinization obstructing hair follicles. It is often linked to and dry skin conditions, with genetic factors contributing to mutations in some cases. The disorder affects approximately 40% of adults and 50-80% of adolescents, with spontaneous resolution occurring in about 50% of cases by adulthood. Lichen simplex chronicus develops as thickened, lichenified plaques from repetitive scratching or rubbing of pruritic skin areas, leading to hyperkeratosis and epidermal as a secondary response to chronic . This condition is frequently associated with , anxiety, or underlying pruritic disorders, perpetuating an itch-scratch cycle. It impacts up to 12% of the general population, with a higher incidence in women and those with .

Site-Specific and Follicular Types

Site-specific hyperkeratosis manifests as localized epidermal thickening confined to particular anatomical regions, often triggered by mechanical or environmental factors. Acquired represents a non-hereditary form characterized by diffuse or focal hyperkeratosis on the palms and soles, frequently resulting from chronic or repeated mechanical trauma over bony prominences, leading to callosities or thickened plaques. This condition typically develops in adulthood and may present asymmetrically, with involvement exceeding 50% of the acral surface in severe cases, distinguishing it from simple frictional calluses by its persistence and potential for fissuring or secondary . Unlike hereditary variants, these acquired forms often resolve or improve upon removal of the inciting , such as through occupational changes or protective measures. Follicular hyperkeratosis involves the abnormal plugging of follicles, resulting in rough, toad-like papules predominantly on extensor surfaces of the limbs. A classic example is phrynoderma, a distinctive manifestation linked to , where follicular occlusion leads to dry, scaly eruptions that may extend to the trunk and buttocks. This nutritional disorder arises from impaired epidermal differentiation due to shortage, often in settings of or dietary inadequacy, and is reversible with supplementation, highlighting its acquired nature. While primarily associated with , similar follicular patterns can occasionally stem from deficiencies in other nutrients like essential fatty acids, though remains the predominant etiology. Subungual hyperkeratosis refers to the accumulation of keratinous debris beneath the nail plate, commonly observed in where chronic of the nail causes and detachment. This leads to a thickened, crumbly subungual material that elevates the nail, often appearing yellowish or whitish, and frequently coexists with , the separation of the nail plate from the along the distal edge. Subungual hyperkeratosis is one of the most common manifestations of nail , increasing susceptibility to secondary infections due to the disrupted barrier. The mechanism involves psoriatic proliferation extending to the , resulting in parakeratotic scaling and nail plate distortion without inherent genetic predisposition in this context. Perioral and facial variants of follicular hyperkeratosis arise from acantholytic dyskeratosis, a histopathological process featuring suprabasal acantholysis and dyskeratotic cells, producing warty, crusted papules in seborrheic distributions that mimic hereditary Darier's disease but occur in acquired, localized forms. These lesions, often pruritic and exacerbated by heat or occlusion, may present as cobblestone-like plaques around the mouth or on the cheeks, driven by transient epidermal adhesion defects rather than genetic mutations. Such patterns can overlap with common cutaneous hyperkeratoses like actinic damage but are distinguished by their follicular emphasis and acantholytic features on biopsy.

Hereditary Types

Hereditary types of hyperkeratosis encompass a group of rare genetic disorders characterized by abnormal keratinization leading to widespread or patterned thickening of the skin, often presenting from birth or . These conditions arise from mutations in genes encoding structural proteins essential for epidermal integrity, resulting in disrupted desmosomal or keratin filament functions. Unlike acquired forms, hereditary hyperkeratosis typically follows autosomal dominant patterns, though recessive cases occur, and manifests systemically rather than being confined to specific sites. Epidermolytic hyperkeratosis, also known as bullous ichthyosiform erythroderma or , is a prototypical hereditary form caused by heterozygous mutations in the KRT1 or KRT10 genes, which encode suprabasal keratins 1 and 10. These mutations lead to cytoskeletal fragility in , resulting in blistering and erosions at birth due to mechanical trauma, followed by the development of hyperkeratotic, ridged scaling across the body, particularly pronounced in flexural areas. The condition has a of approximately 1 in 200,000 to 300,000 live births and is associated with secondary features such as erythroderma and potential palmoplantar involvement. Gene-specific mechanisms, including tonofilament clumping, are detailed in discussions of genetic causes. Nonepidermolytic palmoplantar keratoderma (NEPPK) represents another key hereditary variant, featuring diffuse or focal non-blistering thickening of the palms and soles without the epidermolysis seen in its epidermolytic counterpart. This disorder is linked to mutations at multiple genetic loci, including DSG1 (desmoglein 1), DSP (desmoplakin), and TRPV3 (transient receptor potential cation channel subfamily V member 3), which impair desmosomal adhesion and epidermal barrier function. Clinical presentation includes yellow-brown hyperkeratosis that may extend to nails or joints, often without widespread body involvement, and inheritance is typically autosomal dominant with variable penetrance. Management focuses on emollients and keratolytics to alleviate symptoms, as no curative therapy exists. Striate palmoplantar keratoderma, a subtype of NEPPK, is distinguished by linear, zebra-like patterns of hyperkeratosis confined to the palms and soles, stemming primarily from heterozygous mutations in the DSP gene encoding desmoplakin, a desmosomal plaque protein crucial for intermediate filament anchoring. These mutations cause haploinsufficiency or dominant-negative effects, leading to desmosome instability and longitudinal fissures that worsen with friction or heat. The condition may coexist with ectodermal dysplasia features, such as woolly hair or dental anomalies in recessive forms like Carvajal syndrome, and has an estimated prevalence below 1 in 1,000,000. Symptom management through topical therapies and avoidance of triggers remains the mainstay, with no definitive cure available.

Mucous Membrane Involvement

Oral Hyperkeratosis

Oral hyperkeratosis refers to the excessive accumulation of in the , resulting in white, thickened plaques that may indicate underlying irritation, infection, or precancerous changes. This condition is particularly significant in the oral cavity due to its potential for , necessitating careful clinical evaluation. Common presentations include , nicotinic stomatitis, and , each linked to specific risk factors and exhibiting distinct morphological features. Leukoplakia is the most prevalent form of oral hyperkeratosis, clinically defined as a persistent white patch or plaque on the that cannot be scraped off or attributed to another diagnosable condition. It is strongly associated with chronic use, including and smokeless forms, as well as alcohol consumption, which synergistically promote epithelial proliferation and genetic alterations leading to hyperkeratosis. The annual malignant transformation rate to oral is approximately 1-5%, underscoring its precancerous potential, though rates vary based on lesion size, site, and dysplasia grade. A benign variant, frictional keratosis, develops from repetitive mechanical trauma, such as habitual cheek biting (), resulting in shaggy, irregular white lesions along the buccal mucosa that resolve upon cessation of the habit. Nicotinic stomatitis, also termed smoker's palate, represents a reactive hyperkeratosis confined to the , predominantly in pipe or smokers exposed to high temperatures and irritants. It appears as diffuse white, leathery plaques with fissured surfaces and punctate red dots corresponding to inflamed minor duct orifices, reflecting chronic thermal and chemical injury to the ductal . This condition is generally benign but signals significant exposure, with potential for progression if persists. Hairy leukoplakia is a distinctive, EBV-driven hyperkeratosis observed mainly in immunocompromised patients, particularly those with , due to viral replication in the upper epithelial layers. It manifests as , vertically corrugated, white plaques with a "hairy" or shaggy texture, typically on the lateral borders of the , and does not rub off with scraping. Unlike other forms, it is not directly linked to but serves as an early indicator of , with lesions often resolving upon immune reconstitution. Diagnosis of oral hyperkeratosis relies on incisional as the gold standard to differentiate benign reactive changes from dysplastic or malignant processes, allowing histopathological assessment of thickness, epithelial , and invasion. is essential for all persistent white lesions to evaluate malignant risk, with follow-up surveillance recommended for non-dysplastic cases. Emerging evidence indicates low but notable HPV prevalence (around 6-7%) in , particularly high-risk types like HPV-16, though its etiological role remains limited compared to .

Other Mucosal Hyperkeratosis

Hyperkeratosis affecting non-oral mucosal sites, such as the genital and esophageal regions, manifests in specific clinical contexts and is generally rare in the general population, with an overall prevalence under 1%, though it increases in cases of chronic irritation or underlying genetic predispositions. Vulvar and vaginal hyperkeratosis is prominently associated with lichen sclerosus, a chronic inflammatory dermatosis characterized by the development of ivory-white plaques with a waxy, atrophic appearance on the vulvar mucosa. These plaques result from orthokeratotic hyperkeratosis, where the stratum corneum thickens due to epidermal proliferation and inflammation. The condition is linked to autoimmunity, with over 25% of patients exhibiting comorbid autoimmune diseases such as thyroiditis, and evidence of autoantibodies against extracellular matrix protein 1 (ECM1); genetic associations include HLA-DQ7 alleles in up to 50% of affected women. Prevalence of vulvar lichen sclerosus ranges from 0.1% to 0.3% in the general female population, rising to 1.7% in gynecological practices and up to 3% in women over 80. Chronic irritation from friction or moisture can exacerbate hyperkeratotic changes, leading to fissuring and scarring. In males, penile hyperkeratosis occurs in balanitis xerotica obliterans (BXO), the genital form of , primarily affecting the , prepuce, and coronal sulcus with sclerotic, whitish plaques and epidermal thickening. Histologically, it features orthokeratotic hyperkeratosis alongside dermal sclerosis and epithelial , often triggered by chronic inflammation in uncircumcised individuals. This condition carries a significant risk of due to foreskin constriction from fibrous scarring, accounting for approximately 85% of acquired cases and complicating up to 40% of pediatric circumcisions for . Prevalence mirrors that of at 0.1% to 0.3% overall, with higher rates (5% to 8.9%) in uncircumcised boys and increased incidence in adults over 60. Autoimmune mechanisms similar to vulvar are implicated, though chronic irritation from poor hygiene elevates risk in affected populations. Esophageal hyperkeratosis is a rare manifestation, most notably linked to tylosis with esophageal cancer (TOC), an autosomal dominant caused by RHBDF2 gene mutations. In this condition, hyperplastic squamous mucosa with hyperkeratosis and parakeratosis appears endoscopically as small white plaques scattered throughout the , serving as precursor lesions. TOC predisposes individuals to a high lifetime risk of esophageal , estimated at 40% to 95% by age 65 in affected families, though the syndrome's overall population frequency remains unknown and exceedingly low. Chronic esophageal irritation may contribute to these changes, but the genetic basis drives the malignant potential.

Diagnosis

Clinical Features

Hyperkeratosis manifests as areas of thickened, rough, and scaly due to excessive accumulation of in the . These lesions often appear as hyperpigmented or white plaques, which can be discrete or diffuse, and may range in texture from soft and bran-like scales to hard, adherent crusts. The condition is frequently , but affected individuals may experience pruritus, pain, or discomfort, particularly in areas subject to or . Common clinical presentations include discrete lesions such as corns and calluses, which form as localized hyperkeratotic thickenings on pressure points like the feet, versus more widespread diffuse scaling seen in ichthyosis-like conditions. In inflammatory dermatoses like , plaques may exhibit silvery scales overlying erythematous bases. These variations aid in initial clinical assessment, distinguishing benign frictional responses from broader cutaneous disorders. Associated symptoms can include , especially in actinic forms where lesions become friable and prone to ulceration upon minor trauma. In palmoplantar types, nail changes such as subungual hyperkeratosis, thickening, and discoloration are common, often leading to onychodystrophy. Benign forms of hyperkeratosis typically remain stable over time without progression, while precancerous variants like carry a risk of evolving into in approximately 10% of cases. Histological examination may confirm the diagnosis in ambiguous presentations.

Diagnostic Tests

Diagnosis of hyperkeratosis often requires confirmatory laboratory and imaging tests to distinguish it from other dermatological conditions, particularly when clinical features such as thickened, scaly plaques suggest the need for further evaluation. Skin biopsy remains the gold standard for diagnosing hyperkeratosis, involving the removal of a small skin sample for histopathological examination. Microscopic analysis typically reveals compact orthokeratosis, characterized by thickening of the stratum corneum with retained keratinocyte maturation and absence of nuclear remnants in the cornified layer. In cases suspicious for underlying disorders like ichthyosis vulgaris, special immunohistochemical stains for filaggrin can detect deficiencies associated with filaggrin gene mutations, while keratin-specific stains, such as those targeting KRT1 or KRT10, help identify epidermolytic hyperkeratosis by highlighting abnormal keratin filament aggregation. Dermoscopy, a non-invasive imaging technique using a handheld dermatoscope, aids in the initial assessment of hyperkeratotic lesions, particularly . It reveals characteristic vascular patterns, including the "strawberry-like" appearance in nonpigmented on the face, marked by red dots or globules superimposed on a white, scaly background, which correlates with subepidermal vascular proliferation. This method improves diagnostic accuracy by guiding site selection and differentiating hyperkeratosis from benign seborrheic keratoses or malignant precursors. For hereditary forms of hyperkeratosis, such as palmoplantar keratodermas or , is essential to confirm causative mutations. Targeted sequencing of genes, including KRT1, KRT9, KRT10, and KRT6C, identifies pathogenic variants responsible for disrupted filament assembly leading to epidermal fragility and hyperkeratosis. In hyperkeratotic , (PCR) assays detect human papillomavirus (HPV) DNA, particularly types 1, 2, 27, and 57, from scrapings or swabs, confirming viral with high sensitivity in lesional material. As of 2025, advances in (AI)-assisted dermoscopy have shown potential to enhance the specificity of diagnosing precancerous hyperkeratotic lesions like .

Management and Treatment

Non-Invasive Therapies

Non-invasive therapies for hyperkeratosis primarily involve topical agents that promote exfoliation, hydration, and normalization of cell turnover, with systemic options reserved for severe or hereditary cases. These treatments aim to reduce excessive buildup without requiring invasive procedures, focusing on daily application to affected areas for gradual improvement. Keratolytics such as (in concentrations of 10-40%) and creams are commonly used to soften and exfoliate hyperkeratotic skin by breaking down the bonds between proteins, facilitating . acts as both a keratolytic and , enhancing skin barrier function while dissolving excess . , often combined with (e.g., 10% with 20% ), similarly disrupts structure to treat conditions like palmoplantar hyperkeratosis or . These agents are typically applied once or twice daily for 4-6 weeks, with gradual reduction in thickness observed over this period. Emollients, including petroleum-based moisturizers like petrolatum, play a supportive role in preventing recurrence, particularly in dry types prone to hyperkeratosis. These occlusive agents create a protective barrier to lock in , reducing and alleviating scaling and itching associated with xerotic conditions. Applied liberally after or keratolytic use, emollients help maintain hydration and minimize flare-ups. Topical retinoids, such as tretinoin, are effective for , a precancerous form of hyperkeratosis, by promoting epidermal differentiation and reducing formation. Applied nightly in 0.025-0.1% cream formulations, tretinoin has been shown to decrease the number of actinic keratoses by approximately 30% after 3-6 months of treatment. This efficacy stems from its ability to modulate proliferation and enhance production, though irritation may necessitate initial low dosing. For severe hereditary forms, such as palmoplantar keratodermas, systemic retinoids like offer broader control by inhibiting hyperproliferation at a molecular level. Dosing typically starts at 0.5-1 mg/kg daily, titrated based on response and tolerance, with treatment durations extending months to years for sustained remission. Monitoring for side effects, including , is essential due to acitretin's impact on , often requiring baseline and periodic lipid panels.

Surgical and Procedural Interventions

Surgical and procedural interventions for hyperkeratosis target persistent or precancerous lesions through physical removal or targeted destruction, often providing rapid clearance when non-invasive options are insufficient. These methods are particularly useful for localized or thick plaques, minimizing recurrence in treated areas while preserving surrounding tissue. Cryotherapy involves applying liquid nitrogen to freeze and destroy hyperkeratotic actinic lesions, inducing necrosis of abnormal keratinocytes through rapid freezing and thawing cycles. This outpatient procedure typically requires a single session with a freeze time of 10-20 seconds per lesion, achieving clearance rates of 75-99% for individual actinic keratoses. Common side effects include temporary blistering and hypopigmentation, resolving within weeks, making it suitable for superficial lesions on sun-exposed areas. Laser ablation, particularly with CO2 lasers, vaporizes thick hyperkeratotic plaques such as those in by delivering precise thermal energy to ablate tissue layers. Ablative CO2 lasers achieve single-session clearance in up to 90% of lesions, offering excellent cosmetic outcomes with minimal scarring due to controlled depth penetration. The procedure is performed under , with post-treatment and crusting lasting 7-14 days, and is preferred for cosmetically sensitive sites like the face. Curettage and electrodesiccation combine mechanical scraping with electrical to remove and desiccate benign hyperkeratotic growths, such as seborrheic keratoses, by excising the and coagulating underlying vessels to prevent bleeding. This technique yields high efficacy, with clearance rates around 87.5% for seborrheic keratoses, and is effective for small to medium-sized s due to its simplicity and low cost. Performed in an office setting, it results in a superficial that heals with minimal downtime, though may occur in darker types. Photodynamic therapy (PDT) employs topical (ALA) applied to hyperkeratotic areas, followed by light activation to generate that selectively destroy precancerous cells. This approach is a recommended field-directed for treating in per 2025 expert consensus guidelines, effectively addressing multiple subclinical lesions across large areas with sustained remission rates exceeding 70%. Sessions involve 1-3 hours of incubation before blue or red light exposure, with mild pain managed by cooling, and cosmetic results superior to for facial involvement.

Veterinary Aspects

In Dogs

Hyperkeratosis in dogs primarily affects the of the paw pads and nasal planum, resulting in excessive thickening and hardening due to overproduction of , the protein that forms the outer layer. This condition often presents as dry, cracked, or fissured that can lead to , lameness, and secondary bacterial or fungal infections if untreated. Breeds such as Irish Terriers show a genetic predisposition to naso-plantar , involving both the and footpads, while Dogues de Bordeaux are prone to hereditary footpad hyperkeratosis characterized by progressive paw pad cracking starting in early adulthood. The causes of hyperkeratosis in dogs can be idiopathic, where no underlying trigger is identified and it manifests as a benign, non-progressive disorder typically in middle-aged to older animals, or secondary to systemic issues such as zinc-responsive dermatosis, which impairs and is more common in breeds like Siberian Huskies and Alaskan Malamutes fed imbalanced diets. Parasitic infections like , caused by , also induce hyperkeratosis through chronic inflammation, particularly in endemic regions, leading to crusty lesions on the muzzle and pads alongside systemic signs. The prevalence of idiopathic nasodigital hyperkeratosis is estimated at approximately 0.4% of canine cases, though it appears more frequently—up to 30% in certain predisposed breeds like —and is commonly observed in s over 8 years old as an age-related change. Affected dogs exhibit crusty, hyperpigmented plaques on the paw pads and nasal planum that fissure easily, predisposing to secondary infections and discomfort during ambulation; in severe cases, hair-like keratin projections may emerge from the pads. A genetic basis is evident in some lineages, with autosomal recessive inheritance patterns linked to mutations in genes regulating keratinization, such as FAM83G in Irish Terriers and KRT16 frameshift variants in Dogues de Bordeaux, leading to focal non-epidermolytic . As of 2025, breed-specific genetic panels from providers like Embark and Wisdom Panel enable identification of KRT family mutations in predisposed breeds, facilitating early screening and informed breeding decisions to reduce incidence. These tools build on seminal studies identifying monogenic , emphasizing the role of disrupted filament assembly in .

In Other Animals

Hyperkeratosis in cats is a rare condition, primarily manifesting as excessive buildup on the pads and occasionally the ears, leading to thickened, crusty lesions that can cause discomfort and secondary infections. This disorder is often linked to nutritional deficiencies, particularly , which impairs normal epithelial differentiation and promotes abnormal keratinization. Although true is uncommon in well-fed domestic cats, it has been documented in cases of imbalanced diets, resulting in hyperkeratotic changes alongside other dermatologic signs. Treatment typically involves dietary correction with supplementation at doses around 1,000 IU/kg, alongside topical management to soften the layers. In , hyperkeratosis frequently arises as a complication of chronic pastern dermatitis, also known as scratches or mud fever, where prolonged exposure to wet, muddy environments irritates the skin of the pastern region, especially in breeds with heavy feathering such as drafts. The condition progresses from initial and crusting to marked hyperkeratosis, characterized by thickened, scaly that can and lead to lameness if untreated. Environmental , including keeping the area dry and clean, combined with topical antiseptics and keratolytics, is essential for resolution, as the disorder reflects a reactive pattern rather than a primary genetic defect. Among , zinc-responsive hyperkeratosis is notable in , particularly in herds with dietary zinc deficiencies, where it presents as a parakeratotic dermatosis mimicking in humans. Affected calves exhibit crusting, alopecia, and hyperkeratotic plaques around the mouth, eyes, and extremities, often accompanied by and poor growth; this condition can be significant in deficient herds, though prevalence varies with soil and feed quality. Supplementation with at 1-2 mg/kg body weight corrects the deficiency, restoring normal barrier function and preventing mortality in severe cases. Similar zinc-related disorders occur sporadically in sheep and under nutritional stress. Comparative studies leverage animal models to elucidate hyperkeratosis mechanisms relevant to disease, such as mouse models with (KRT) gene knockouts. For instance, 10 (KRT10) knockout mice recapitulate recessive , featuring basal cell degeneration, hyperproliferation, and thickened , providing insights into cytoskeletal integrity and therapeutic targets like retinoids for inherited ichthyoses. These models highlight conserved pathways in differentiation across , aiding into both veterinary and hyperproliferative disorders without direct zoonotic implications.

Terminology

Etymology

The term hyperkeratosis derives from New Latin, combining the Greek prefix hyper- (ὑπέρ), meaning "over" or "excessive," with kerato-, from the Greek kéras (κέρας) or kerat-, denoting "horn" and referring to , the fibrous protein that forms the outer layer of , , and , and the -osis, from Greek -ωσις, indicating an abnormal condition or process. The term was first introduced in 1819 by German ophthalmologist Karl Himly to describe , an eye condition. It entered English usage in 1841, initially by British surgeon William Lawrence to describe conditions involving excessive horny tissue formation, such as in ocular contexts like conical , building on earlier observations of horn-like growths dating back to ancient descriptions of cutaneous disorders. It evolved from the related term keratosis, which was formalized in the mid-19th century; German physician Hermann Lebert promulgated (from German Keratose) in his 1864 treatise Ueber Keratose, oder die durch Bildung von Hornsubstanz erzeugten Krankheiten und ihre Behandlung, focusing on diseases caused by abnormal horn-like substance production in the skin. In 20th-century pathology texts, hyperkeratosis became distinctly specified to denote the pathological thickening of the due to excess , distinguishing it from general keratosis in dermatological contexts.

Pronunciation

The term hyperkeratosis is pronounced in standard American English as /ˌhaɪ.pərˌker.əˈtoʊ.sɪs/ in the International Phonetic Alphabet (IPA), with primary stress on the fourth ("to"). The syllabic breakdown is hy-per-ker-a-to-sis, emphasizing the reduced vowels in unstressed positions for natural flow. In , the variant is /ˌhaɪ.pə.kɛr.əˈtəʊ.sɪs/, featuring a shorter "e" in the third and a in the fourth. A frequent mispronunciation omits the schwa (/ə/) sounds, rendering it as "hyper-kerato-sis" with overly distinct s, which alters the medical term's rhythmic quality. Audio pronunciations are available in medical reference resources, including the Dictionary of Cancer Terms and Taber's Cyclopedic Medical Dictionary (2025 edition). This guidance aligns with the term's etymological origins from Greek roots, as explored in the section.

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK562206/
  2. https://www.webmd.com/skin-problems-and-treatments/hyperkeratosis
  3. https://dermnetnz.org/topics/dermatopathological-terminology
  4. https://www.oed.com/dictionary/hyperkeratosis_n
  5. https://academic.oup.com/bjd/article/190/4/465/7331269
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC4533794/
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC10410087/
  8. https://emedicine.medscape.com/article/1099775-overview
  9. https://www.ncbi.nlm.nih.gov/books/NBK557401/
  10. https://www.unboundmedicine.com/5minute/view/5-Minute-Clinical-Consult/1688676/1.3.0/Corns_and_Calluses
  11. https://www.sciencedirect.com/science/article/pii/S0022202X15363569
  12. https://academic.oup.com/bjd/article-pdf/190/4/465/56986216/ljad371.pdf
  13. https://www.jidonline.org/article/S0022-202X%2815%2936356-9/fulltext
  14. https://onlinelibrary.wiley.com/doi/10.1111/ajd.14290
  15. https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1674975/full
  16. https://jamanetwork.com/journals/jamadermatology/fullarticle/2834545
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC2861991/
  18. https://www.ncbi.nlm.nih.gov/books/NBK26865/
  19. https://www.mdpi.com/2079-9284/4/4/47
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC5880164/
  21. https://pmc.ncbi.nlm.nih.gov/articles/PMC2736122/
  22. https://www.sciencedirect.com/science/article/pii/S102781171500035X
  23. https://pmc.ncbi.nlm.nih.gov/articles/PMC10779394/
  24. https://pmc.ncbi.nlm.nih.gov/articles/PMC3713412/
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC2291295/
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC4452581/
  27. https://www.mdpi.com/1422-0067/21/4/1194
  28. https://onlinelibrary.wiley.com/doi/10.1111/cod.13572
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC6317863/
  30. https://www.medicalnewstoday.com/articles/320667
  31. https://www.mayoclinic.org/diseases-conditions/actinic-keratosis/symptoms-causes/syc-20354969
  32. https://dermnetnz.org/topics/hyperkeratotic-palmar-dermatitis
  33. https://pubmed.ncbi.nlm.nih.gov/23299695/
  34. https://dermnetnz.org/topics/skin-toxicity-of-chemotherapy-drugs
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC3142884/
  36. https://www.nature.com/articles/ng0294-174
  37. https://pubmed.ncbi.nlm.nih.gov/31823354/
  38. https://www.sciencedirect.com/science/article/pii/S0022202X15352660
  39. https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1007168
  40. https://pubmed.ncbi.nlm.nih.gov/12192490/
  41. https://www.sciencedirect.com/science/article/pii/S0022202X15403434
  42. https://pmc.ncbi.nlm.nih.gov/articles/PMC3375344/
  43. https://www.nature.com/articles/cddis2012152
  44. https://www.jci.org/articles/view/13563
  45. https://rarediseases.org/rare-diseases/pachyonychia-congenita/
  46. https://jamanetwork.com/journals/jamadermatology/fullarticle/2825243
  47. https://www.orpha.net/en/disease/detail/313
  48. https://www.clinicaltrials.gov/study/NCT04047732
  49. https://link.springer.com/article/10.1007/s13555-024-01239-4
  50. https://www.sciencedirect.com/science/article/pii/S2162253118301021
  51. https://clinicaltrials.gov/study/NCT00716014
  52. https://pmc.ncbi.nlm.nih.gov/articles/PMC2839285/
  53. https://my.clevelandclinic.org/health/diseases/hyperkeratosis
  54. https://pmc.ncbi.nlm.nih.gov/articles/PMC6939186/
  55. https://www.ncbi.nlm.nih.gov/books/NBK545285/
  56. https://www.uptodate.com/contents/seborrheic-keratosis/print
  57. https://www.ncbi.nlm.nih.gov/books/NBK546708/
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC8528166/
  59. https://www.ncbi.nlm.nih.gov/books/NBK499991/
  60. https://pmc.ncbi.nlm.nih.gov/articles/PMC3607245/
  61. https://emedicine.medscape.com/article/1108406-overview
  62. https://pubmed.ncbi.nlm.nih.gov/15660900/
  63. https://pmc.ncbi.nlm.nih.gov/articles/PMC4008063/
  64. https://www.sciencedirect.com/topics/medicine-and-dentistry/acantholytic-dyskeratosis
  65. https://www.ncbi.nlm.nih.gov/books/NBK544323/
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC6196674/
  67. https://pmc.ncbi.nlm.nih.gov/articles/PMC4689080/
  68. https://www.ncbi.nlm.nih.gov/omim/613000
  69. https://pmc.ncbi.nlm.nih.gov/articles/PMC6615398/
  70. https://pmc.ncbi.nlm.nih.gov/articles/PMC5485079/
  71. https://pubmed.ncbi.nlm.nih.gov/9887343/
  72. https://pmc.ncbi.nlm.nih.gov/articles/PMC2914539/
  73. https://pubmed.ncbi.nlm.nih.gov/10594734/
  74. https://pmc.ncbi.nlm.nih.gov/articles/PMC9326939/
  75. https://www.ncbi.nlm.nih.gov/books/NBK538246/
  76. https://pmc.ncbi.nlm.nih.gov/articles/PMC6970240/
  77. https://pubmed.ncbi.nlm.nih.gov/7888355/
  78. https://onlinelibrary.wiley.com/doi/10.1111/ajd.14434
  79. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1106318/full
  80. https://www.pathologyoutlines.com/topic/penscrotumbxo.html
  81. https://www.ncbi.nlm.nih.gov/books/NBK567770/
  82. https://ojrd.biomedcentral.com/articles/10.1186/s13023-015-0346-2
  83. https://karger.com/cro/article/12/2/385/91211/Uncommon-Endoscopic-Findings-in-a-Tylosis-Patient
  84. https://pmc.ncbi.nlm.nih.gov/articles/PMC10564211/
  85. https://pubmed.ncbi.nlm.nih.gov/17760601/
  86. https://www.pathologyoutlines.com/topic/skinnontumorcommonterms.html
  87. https://www.mdpi.com/1422-0067/23/3/1455
  88. https://pubmed.ncbi.nlm.nih.gov/2419891/
  89. https://dermnetnz.org/topics/actinic-keratosis-dermoscopy
  90. https://pmc.ncbi.nlm.nih.gov/articles/PMC11566822/
  91. https://medlineplus.gov/genetics/gene/krt1/
  92. https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.27514
  93. https://onlinelibrary.wiley.com/doi/10.1111/ijd.17981
  94. https://www.mdpi.com/2673-6179/5/2/9
  95. https://pmc.ncbi.nlm.nih.gov/articles/PMC8611129/
  96. https://www.sciencedirect.com/topics/medicine-and-dentistry/keratolytic-agent
  97. https://www.pagepress.org/journals/dr/article/view/9072/8645
  98. https://www.welshwoundnetwork.org/files/5814/1260/1779/hyperkeratosis.pdf
  99. https://pubmed.ncbi.nlm.nih.gov/3534022/
  100. https://pmc.ncbi.nlm.nih.gov/articles/PMC3760934/
  101. https://pubmed.ncbi.nlm.nih.gov/8763418/
  102. https://www.sciencedirect.com/science/article/abs/pii/019096229170158X
  103. https://www.ncbi.nlm.nih.gov/books/NBK519571/
  104. https://pmc.ncbi.nlm.nih.gov/articles/PMC4436237/
  105. https://www.aafp.org/pubs/afp/issues/2004/0515/p2365.html
  106. https://pubmed.ncbi.nlm.nih.gov/40937913/
  107. https://ijdvl.com/standard-guidelines-of-care-co-2-laser-for-removal-of-benign-skin-lesions-and-resurfacing/
  108. https://pubmed.ncbi.nlm.nih.gov/40619638/
  109. https://www.jaadinternational.org/article/S2666-3287(25)00022-7/fulltext
  110. https://www.ncbi.nlm.nih.gov/books/NBK617062/
  111. https://toegrips.com/dog-nose-hyperkeratosis/
  112. https://open.lib.umn.edu/animaldermatology2/chapter/hereditary-keratinization-disorders-familial-nasal-parakeratosis-and-footpad-hyperkeratosis-dogs/
  113. https://www.petmd.com/dog/conditions/skin/hyperkeratosis-dogs
  114. https://www.researchgate.net/publication/274689193_Idiopathic_Nasodigital_Hyperkeratosis_in_Dogs_A_Retrospective_Analysis_of_35_Cases_1988ndash1998
  115. https://vcahospitals.com/know-your-pet/leishmaniasis-in-dogs
  116. https://embarkvet.com/products/dog-health/health-conditions/hereditary-footpad-hyperkeratosis/
  117. https://www.wisdompanel.com/en-us/dog-health-conditions/hfh
  118. https://www.msdvetmanual.com/pharmacology/systemic-pharmacotherapeutics-of-the-integumentary-system/vitamins-and-minerals-for-integumentary-disease-in-animals
  119. https://www.researchgate.net/publication/287393970_Utilization_metabolism_significance_and_application_of_vitamin_A_in_the_dog_and_cat
  120. https://ceh.vetmed.ucdavis.edu/health-topics/pastern-dermatitis-scratches
  121. https://avmajournals.avma.org/view/journals/javma/261/S1/javma.22.12.0569.xml
  122. https://www.cabidigitallibrary.org/doi/pdf/10.5555/20143279680
  123. https://pubmed.ncbi.nlm.nih.gov/58525/
  124. https://pubmed.ncbi.nlm.nih.gov/16505000/
  125. https://www.merriam-webster.com/dictionary/hyperkeratosis
  126. https://www.jstor.org/stable/25493878
  127. https://www.merriam-webster.com/dictionary/keratosis
  128. https://www.howtopronounce.com/hyperkeratosis
  129. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hyperkeratosis
  130. https://www.tabers.com/tabersonline/view/Tabers-Dictionary/758851/all/hyperkeratosis_congenitalis
Add your contribution
Related Hubs
User Avatar
No comments yet.